1699results about How to "Inhibition is effective" patented technology

A liquid material vaporization apparatus for a semiconductor processing apparatus includes: a vaporization tank; an inner partition wall disposed in the tank for dividing the interior of the tank into a charging compartment and a vaporization compartment which are liquid-communicatable with each other over an upper edge of the inner partition wall. A liquid material charged in the charging compartment overflows over the upper edge of the inner partition wall toward the vaporization compartment to store and vaporize the liquid material in the vaporization compartment.

A liquid material vaporization apparatus for a semiconductor processing apparatus includes: a vaporization tank; an inner partition wall disposed in the tank for dividing the interior of the tank into a charging compartment and a vaporization compartment which are liquid-communicatable with each other over an upper edge of the inner partition wall. A liquid material charged in the charging compartment overflows over the upper edge of the inner partition wall toward the vaporization compartment to store and vaporize the liquid material in the vaporization compartment.

A method of depositing a silicon oxide film on a resist pattern or etched lines formed on a substrate by plasma enhanced atomic layer deposition (PEALD) includes: providing a substrate on which a resist pattern or etched lines are formed in a PEALD reactor; controlling a temperature of a susceptor on which the substrate is placed at less than 50° C. as a deposition temperature; introducing a silicon-containing precursor and an oxygen-supplying reactant to the PEALD reactor and applying RF power therein in a cycle, while the deposition temperature is controlled substantially or nearly at a constant temperature of less than 50° C., thereby depositing a silicon oxide atomic layer on the resist pattern or etched lines; and repeating the cycle multiple times substantially or nearly at the constant temperature to deposit a silicon oxide atomic film on the resist pattern or etched lines.

A method for forming an oxide film by plasma-assisted processing includes: (i) supplying a precursor reactive to none of oxygen, CxOy, and NxOy (x and y are integers) without a plasma to a reaction space wherein a substrate is placed; (ii) exposing the precursor to a plasma of CxOy and / or NxOy in the reaction space; and (iii) forming an oxide film on the substrate using the precursor and the plasma.

Disclosed is a Security Indications and Warning (SI&W) Engine usable in conjunction with an audit agent. The audit agent forwards normalized audits to the SI&W Engine. The SI&W Engine groups the normalized audits into related groupings. Gauges are used to count the number of occurrences of audited events. A statistical engine provides statistical representations of the number of events per user, per session and per node. A predetermined number of criteria are defined a particular gauge or gauge pair. There may be many criteria for a particular network. When a predetermined number of criteria within a criteria set are triggered, an indicator is triggered. More complex indicators can use combinations of lower level indicators to provide further indications of potential security threads. Thus, a hierarchical system of gauges, criteria and indicators is used to measure boundary violations and breaches of different barriers. Advantageously, because there are no predefined scenarios or profiles that must be performed by a potential misuser or intruder, the SI&W Engine of the present invention is capable of indicating that a potential security threat exists in near-real time.

The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human serum albumin and / or deferoxamine. The human serum albumin is present in an amount effective to reduce one or more side effects associated with administration of the pharmaceutical composition. The invention also provides methods for reducing one or more side effects of administration of the pharmaceutical composition, methods for inhibiting microbial growth and oxidation in the pharmaceutical composition, and methods for enhancing transport and binding of a pharmaceutical agent to a cell.

A semiconductor device (100) comprises a first resin substrate (101) on which a first semiconductor chip (125) is mounted a surface thereof; a second resin substrate (111) on which a second semiconductor chip (131) is mounted on a surface thereof; and a resin base material (109), joined to a front surface of the first resin substrate (101) and to a back surface of the second resin substrate (111), so that these surfaces are electrically connected. The resin base material (109) is disposed in a circumference of the first resin substrate (101) in the surface of the first resin substrate (101). Further, the first semiconductor chip (125) is disposed in a space section provided among the first resin substrate (101), the second resin substrate (111) and the resin base material (109) in the surface of the first resin substrate (101).

The present invention is directed to aneurysm treatment devices which are capable of being delivered to the situs of a vascular aneurysm through a catheter. The treatment devices comprise, in general, an expandable stent having fenestrations and a reactive material selectively applied to not all of the fenestrations. The reactive material has a non-reacted state and a reacted state and the reactive material in the reacted state is capable of increasing the resistance to blood flow through said fenestrations.

A thermoplastic dicyclopentadiene ring-opening polymer obtained by ring-opening polymerization of a monomer component containing a dicyclopentadiene monomer, characterized in that polycyclic rings which are repeating units of the polymer are bonded in cis-position relative to the carbon-carbon double bond of the main chain of the polymer in 50 mol % or more of the repeating units based on the total repeating units and the content of a low-molecular weight component of 2,000 or less in molecular weight is 10% by weight or less based on the total polymer components, and a hydrogenation product obtained by hydrogenating the carbon-carbon unsaturated bond of the thermoplastic dicyclopentadiene ring-opening polymer.

A deposition mask and a display unit and method of manufacturing same are provided. A red continuous organic layer, a green continuous organic layer, and a blue continuous organic layer are provided over two or more lines of a matrix configuration of organic light emitting devices in common. A film thickness distribution in the extensional direction of the red, green and blue continuous organic layer is dissolved, and an aperture ratio can be improved by just that much.

The present invention relates to a novel imidazole derivative represented by formula (1) which shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts or isomers thereof, in which A, n1 and Y are defined in the specification; to a process for preparation of the compound of formula (1); to intermediates which are used in the preparation of the compound of formula (1); and to a pharmaceutical composition comprising the compound of formula (1) as an active ingredient.

The present invention relates to a novel piperidine derivative represented by formula (1) which shows an inhibitory activity against farnesyl transferase or pharmaceutically acceptable salts thereof, in which A, E and G are defined in the specification; to a process for preparation of the compound of formula (1); to an intermediate which is used in the preparation of the compound of formula (1); and to a pharmaceutical composition comprising the compound of formula (1) as an active ingredient.

The invention relates to peptide conjugates including at least one turn inducer wherein the turn inducer comprises a 5-7 membered saturated or unsaturated nitrogen containing heterocyclic ring and methods of making the peptides. Libraries of these peptides, methods of making the libraries are also described and methods of screening the libraries for therapeutic activity are also described.

The present invention is directed to aneurysm treatment devices which are capable of being delivered to the situs of a vascular aneurysm through a catheter. The treatment devices comprise, in general, a body member formed by at least one support member and a reactive material selectively applied to the at least one support member. The body member provide support mechanical support to a weakened or otherwise incompetent blood vessel. The reactive material is capable of restricting or occluding blood flow to the aneurysm, without substantially affecting blood flow through the blood vessel.

The present invention provides new heterocyclic compounds, particularly substituted pyrimidines, methods and compositions for making and using these heterocyclic compounds, and methods for treating a variety of diseases and disease states, including atherosclerosis, arthritis, restenosis, diabetic nephropathy, or dyslipidemia, or disease states mediated by the low expression of Perlecan.

The invention provides a nonaqueous electrolyte secondary battery excellent in output characteristic such as large current discharge or pulse discharge in ordinary use, high in safety by preventing destruction due to suppression of current in an abnormality such as external short-circuiting, and further large in capacity. The nonaqueous electrolyte secondary battery comprises an external can opened at one end thereof, an electrode assembly contained in the external can, and comprising a negative electrode, a separator and a positive electrode, a nonaqueous electrolyte contained in the external can, and a sealing lid group tightly sealed at the opening of the external can by way of an insulating member, wherein the sealing lid group includes an intact plate-like PTC element having a fragile portion to be easily broken due to elevation of internal pressure by gas generation.

A negative electrode material for a nonaqueous electrolyte secondary battery having a high discharge capacity and a good cycle life is made from alloy particles having an average particle diameter of 0.1-50 mum and including Si phase grains 40 and a phase of a solid solution or an intermetallic compound of Si and other element selected from Group 2A elements, transition elements, Group 3B elements, and Group 4B elements from the long form periodic table (for example, an NiSi2 phase 42 and an [NiSi2+NiSi] phase 41) at least partially enveloping the Si phase grains. 5-99 wt % of this material is Si phase grains. The alloy particles can be manufactured by rapid solidification (such as atomization or roller quenching) of a melt including Si and the other element, or by adhering the other element to Si powder by electroless plating or mechanical alloying and then performing heat treatment. Even if rapid solidification is carried out, a negative electrode material having a good discharge capacity and cycle life is obtained without heat treatment.

Provided is an antenna coil capable of forming a magnetic field in a desired direction in an efficient manner, while suppressing leakage of magnetic flux into a space other than the space in which the magnetic field is formed. The antenna coil includes a main coil portion formed by winding a length of conductor wire around a first reference axis and an auxiliary coil portion formed by winding the conductor wire around a second reference axis. The second reference axis is set to intersect the magnetic flux of the main coil portion at an axial end of the auxiliary coil portion. The main coil portion and the auxiliary coil portion are connected to together form a closed circuit.

In a simple method and device for producing plasma flows of a metal and / or a gas electric discharges are periodically produced between the anode and a metal magnetron sputtering cathode in crossed electric and magnetic fields in a chamber having a low pressure of a gas. The discharges are produced so that each discharge comprises a first period with a low electrical current passing between the anode and cathode for producing a metal vapor by magnetron sputtering, and a second period with a high electrical current passing between the anode and cathode for producing an ionization of gas and the produced metal vapor. Instead of the first period a constant current discharge can be used. Intensive gas or metal plasma flows can be produced without forming contracted arc discharges. The selfsputtering phenomenon can be used.

The invention relates to a method for controlling a loading process of a transport vehicle by a milling device in milling operation, a device for implementing this method and a road milling machine or a device for the removal of soil material with such a device. An essential aspect of the invention is a sensor device by means of which the position and partially also the fill level of the transport container of the transport vehicle can be determined.

Hepatitis C virus inhibitors are disclosed having the general formula:wherein A, R2, R3, R′, B and Y are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.

A touch screen display device is described that includes a display panel, a display driver, a sensor circuit and a combination unit. The display panel has a plurality of display elements arranged between a first and a second electrode layer. The display driver is arranged for providing display signals comprising a common display signal and an input control signal to the display panel. The sensor circuit is arranged for providing a probe signal and a shield signal mutually having the same phase and frequency and for generating a touch signal in response to the output signal received from the first electrode layer. The combination unit provides a drive signal to the first electrode layer derived from the common display signal and the probe signal, and further provides an output control signal for the display panel from the input control signal and the shield signal.

Hepatitis C virus inhibitors are disclosed having the general formula: wherein R1, R2, R3, R′, B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.